Acquiring Company
Indivior Pharmaceuticals
Acquired Company
Supernus Pharmaceuticals
RockvilleBiotechnologyHealth CareMedicalPharmaceuticalBiotechnologyHealth CareTherapeuticsBiopharmaDescription
Indivior Pharmaceuticals is set to merge with Supernus Pharmaceuticals to enhance its central nervous system portfolio. This all-stock merger aims to create efficiencies and achieve targeted annual cost savings of US$125 million. The integration presents challenges that the companies must address to realize their combined potential. Investors will be monitoring the progress of integration and overall performance closely.
Don't miss Indivior Pharmaceuticals's next move
Get an email the moment Indivior Pharmaceuticals makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
M&A Insights
Based on deal dataFrequently asked
Who acquired Supernus Pharmaceuticals?
Supernus Pharmaceuticals was acquired by Indivior Pharmaceuticals. The deal was reported on August 26, 2026. Indivior Pharmaceuticals, Inc. specializes in the treatment of addiction and is engaged in developing medicines to help individuals with substance use disorders. Indivior Pharmaceuticals is publicly traded (INDV) and operates in Biotechnology.
When did Indivior Pharmaceuticals acquire Supernus Pharmaceuticals?
Indivior Pharmaceuticals's acquisition of Supernus Pharmaceuticals was reported on August 26, 2026. Indivior Pharmaceuticals is set to merge with Supernus Pharmaceuticals to enhance its central nervous system portfolio. This all-stock merger aims to create efficiencies and achieve targeted annual cost savings of US$125 million. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Supernus Pharmaceuticals do?
Supernus Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on developing and commercializing products for the treatment of central nervous system (CNS) diseases. It is publicly traded (SUPN), operating in Biotechnology, and is based in Rockville.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.